GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Proto Script Pharmaceutical Corp (OTCPK:PSCR) » Definitions » Gross Profit

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Gross Profit : $0.35 Mil (TTM As of Sep. 2017)


View and export this data going back to 2011. Start your Free Trial

What is Proto Script Pharmaceutical Gross Profit?

Proto Script Pharmaceutical's gross profit for the three months ended in Sep. 2017 was $0.21 Mil. Proto Script Pharmaceutical's gross profit for the trailing twelve months (TTM) ended in Sep. 2017 was $0.35 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Proto Script Pharmaceutical's gross profit for the three months ended in Sep. 2017 was $0.21 Mil. Proto Script Pharmaceutical's Revenue for the three months ended in Sep. 2017 was $0.25 Mil. Therefore, Proto Script Pharmaceutical's Gross Margin % for the quarter that ended in Sep. 2017 was 84.92%.

Proto Script Pharmaceutical had a gross margin of 84.92% for the quarter that ended in Sep. 2017 => Durable competitive advantage


Proto Script Pharmaceutical Gross Profit Historical Data

The historical data trend for Proto Script Pharmaceutical's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proto Script Pharmaceutical Gross Profit Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
Gross Profit
- - - - -

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 - 0.11 0.03 0.21

Competitive Comparison of Proto Script Pharmaceutical's Gross Profit

For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proto Script Pharmaceutical's Gross Profit Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Gross Profit distribution charts can be found below:

* The bar in red indicates where Proto Script Pharmaceutical's Gross Profit falls into.



Proto Script Pharmaceutical Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Proto Script Pharmaceutical's Gross Profit for the fiscal year that ended in May. 2016 is calculated as

Gross Profit (A: May. 2016 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Proto Script Pharmaceutical's Gross Profit for the quarter that ended in Sep. 2017 is calculated as

Gross Profit (Q: Sep. 2017 )=Revenue - Cost of Goods Sold
=0.252 - 0.038
=0.21

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.35 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Proto Script Pharmaceutical's Gross Margin % for the quarter that ended in Sep. 2017 is calculated as

Gross Margin % (Q: Sep. 2017 )=Gross Profit (Q: Sep. 2017 ) / Revenue (Q: Sep. 2017 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.21 / 0.252
=84.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Proto Script Pharmaceutical  (OTCPK:PSCR) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Proto Script Pharmaceutical had a gross margin of 84.92% for the quarter that ended in Sep. 2017 => Durable competitive advantage


Proto Script Pharmaceutical Gross Profit Related Terms

Thank you for viewing the detailed overview of Proto Script Pharmaceutical's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description

Traded in Other Exchanges
N/A
Address
9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Headlines

No Headlines